Home
>
National Drug Code (NDC)
>
Mestinon
Mestinon - 0187-3013-30 - (pyridostigmine bromide)
Drug Information of Mestinon
| Product NDC: | 0187-3013 |
| Proprietary Name: | Mestinon |
| Non Proprietary Name: | pyridostigmine bromide |
| Active Ingredient(s): | 180 mg/1 & nbsp; pyridostigmine bromide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Mestinon
| Product NDC: | 0187-3013 |
| Labeler Name: | Valeant Pharmaceuticals North America LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA011665 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19590112 |
Package Information of Mestinon
| Package NDC: | 0187-3013-30 |
| Package Description: | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-3013-30) |
NDC Information of Mestinon
| NDC Code | 0187-3013-30 |
| Proprietary Name | Mestinon |
| Package Description | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-3013-30) |
| Product NDC | 0187-3013 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | pyridostigmine bromide |
| Dosage Form Name | TABLET, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 19590112 |
| Marketing Category Name | NDA |
| Labeler Name | Valeant Pharmaceuticals North America LLC |
| Substance Name | PYRIDOSTIGMINE BROMIDE |
| Strength Number | 180 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |
